These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1975977)

  • 1. Neutralizing antibodies and serum interferon levels in the different stages of HIV infection.
    Szabó B; Tóth FD; Kiss J; Ujhelyi E; Füst G; Horváth A; Hollán SR
    Acta Virol; 1990 Apr; 34(2):164-70. PubMed ID: 1975977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus neutralizing antibodies at different stages of the HIV disease: increased levels after azidothymidine treatment.
    Schmidtmayerová H; Lackovicová M; Stanková M; Brůcková M; Surový I; Ujhelyi E; Füst G; Mayer V
    Acta Virol; 1992 Mar; 36(2):157-65. PubMed ID: 1359767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
    Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
    Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and specificity of lymphocytotoxic antibodies in different stages of HIV infection.
    Szabó B; Tóth FD; Kiss J; Füst G; Ujhelyi E; Bánhegyi D; Horváth A; Hollán SR
    Acta Virol; 1992 Aug; 36(4):392-400. PubMed ID: 1362323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of high-avidity rubella-specific IgG antibody and titres in recent HIV seroconvertors and in patients progressing to the AIDS-related complex and AIDS.
    Thomas HI; Aird HC
    J Med Virol; 1999 Jul; 58(3):273-9. PubMed ID: 10447423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection.
    Tóth FD; Szabó B; Ujhelyi E; Pálóczi K; Horváth A; Füst G; Kiss J; Bánhegyi D; Hollán SR
    AIDS; 1991 Mar; 5(3):263-8. PubMed ID: 1676275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgD behaviour in HIV-1 infected patients.
    Raiteri R; Albonico M; Deiana R; Marietti G; Sinicco A
    Allergol Immunopathol (Madr); 1991; 19(1):6-10. PubMed ID: 1950942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic study in HIV-positive patients. Hypergammaglobulinemia in HIV infection].
    Skokanová V; Kamínková J; Vacek Z; Stanková M
    Cas Lek Cesk; 1993 Jun; 132(12):369-72. PubMed ID: 8343945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
    Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
    J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interferon and tumor necrosis factor in the pathogenesis of AIDS.
    Lau AS; Williams BR
    J Exp Pathol; 1990; 5(3):111-22. PubMed ID: 1709966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.
    Ljunggren K; Karlson A; Fenyö EM; Jondal M
    Clin Exp Immunol; 1989 Feb; 75(2):184-9. PubMed ID: 2649286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages.
    Ljunggren K; Broliden PA; Morfeldt-Månson L; Jondal M; Wahren B
    Clin Exp Immunol; 1988 Sep; 73(3):343-7. PubMed ID: 3208446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
    Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
    J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of HIV antigens in cerebrospinal fluid and in serum of patients with both asymptomatic and symptomatic HIV infection].
    Radkowski M; Laskus T; Kopicz-Kamińska E; Mian M; Babiuch L; Slusarczyk J
    Pol Tyg Lek; 1992 Sep 7-14; 47(36-37):784-6. PubMed ID: 1293560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
    Zhao XX; Hua J; Smith T; Ferencz-Biro K; Liao MJ; Rashidbaigi A
    Hum Antibodies; 1997; 8(3):129-36. PubMed ID: 9322083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome.
    Lau AS; Livesey JF
    J Clin Invest; 1989 Sep; 84(3):738-43. PubMed ID: 2503543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
    Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of enhanced interferon alpha levels in sera of HIV-infected and AIDS patients receiving combined antiretroviral therapy.
    Piasecki E; Knysz B; Gasiorowski J; Gładysz A
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):37-44. PubMed ID: 11729827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding antibody to neutralizing epitope gp41 in HIV-1 subtype CRF 01_AE infection related to stage of disease.
    Srisurapanon S; Louisirirotchanakul S; Sumransurp K; Ratanasrithong M; Chuenchitra T; Jintakatkorn S; Wasi C
    Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):221-7. PubMed ID: 15906673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.